United States · FDA National Drug Code directory
Sodium Phosphates
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-884_3ae3c9a3-3503-4264-8c77-00089f50cc74
- Product NDC
- 63323-884
- Form
- INJECTION, SOLUTION
- Composition / generic term
- sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220330
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE — 276 mg/mL
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS — 142 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-884-06) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-884-01) · 63323-884-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →